Published in Nat Genet on August 01, 1998
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Integrative analysis of the melanoma transcriptome. Genome Res (2010) 8.46
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Family-based tests of association in the presence of linkage. Am J Hum Genet (2000) 3.74
8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease. Proteomics (2007) 2.33
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest (1999) 2.21
Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest (2000) 2.11
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet (1999) 2.01
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet (1999) 1.79
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch Neurol (2011) 1.62
Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet (2004) 1.51
Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci (2004) 1.30
A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein. J Cell Biol (1999) 1.28
Genetic aspects of Alzheimer disease. Genet Med (2008) 1.26
Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet (2000) 1.26
Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta (2009) 1.23
Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am J Hum Genet (2001) 1.13
Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics. Mol Psychiatry (2004) 1.13
Chasing genes in Alzheimer's and Parkinson's disease. Hum Genet (2004) 1.11
Amyloid oligomer conformation in a group of natively folded proteins. PLoS One (2008) 1.10
RNA sequencing reveals differential expression of mitochondrial and oxidation reduction genes in the long-lived naked mole-rat when compared to mice. PLoS One (2011) 1.08
Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1. Proteomics (2009) 1.07
A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet (2002) 1.07
An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet (2009) 1.05
The apolipoprotein E gene, attention, and brain function. Neuropsychology (2002) 1.05
Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration. Am J Pathol (2011) 1.04
Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol (2000) 1.04
A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J Clin Invest (1999) 1.03
Endophenotypes in normal brain morphology and Alzheimer's disease: a review. Neuroscience (2009) 1.02
Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease. Biochim Biophys Acta (2008) 1.01
The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease. Cell Adh Migr (2011) 1.00
Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. Proteomics Clin Appl (2012) 0.98
Genetic risk factors in Alzheimer's disease. Mol Pathol (1998) 0.97
Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry (2002) 0.95
Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. J Alzheimers Dis (2010) 0.93
C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65. J Cell Mol Med (2008) 0.92
alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. Am J Pathol (1999) 0.90
Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet (2003) 0.89
Differential expression of alpha 2 macroglobulin in response to dietylstilbestrol and in ovarian carcinomas in chickens. Reprod Biol Endocrinol (2011) 0.88
Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein. Neuroscience (2011) 0.88
Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry (1999) 0.87
Alzheimer disease--when and why? Nat Genet (1998) 0.86
LRP in Alzheimer's disease: friend or foe? J Clin Invest (2000) 0.85
Protein aggregates and dementia: is there a common toxicity? J Neurol Neurosurg Psychiatry (2002) 0.84
The role of lipoprotein receptors on the physiological function of APP. Exp Brain Res (2011) 0.84
Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer's disease. PLoS One (2013) 0.83
Does gamma-aminobutyric acid (GABA) influence the development of chronic inflammation in rheumatoid arthritis? J Neuroinflammation (2008) 0.82
Mouse models of growth hormone action and aging: a proteomic perspective. Proteomics (2012) 0.82
Structure of a rat α₁-macroglobulin receptor-binding domain dimer. Protein Sci (2000) 0.82
Genetic studies in Alzheimer's disease. Dialogues Clin Neurosci (2003) 0.82
Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling. Biochem J (2003) 0.80
Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levels. Front Aging Neurosci (2014) 0.80
Alpha2 macroglobulin-like is essential for liver development in zebrafish. PLoS One (2008) 0.80
Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease. Mol Neurodegener (2010) 0.79
Use of genetic variation as biomarkers for Alzheimer's disease. Ann N Y Acad Sci (2009) 0.79
A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo. Mol Cell Biol (2015) 0.78
Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo. Am J Pathol (1999) 0.78
Cellular basis of Alzheimer's disease. Ann Indian Acad Neurol (2010) 0.77
Prion protein paralog doppel protein interacts with alpha-2-macroglobulin: a plausible mechanism for doppel-mediated neurodegeneration. PLoS One (2009) 0.77
Depletion of potential A2M risk haplotype for Alzheimer's disease in long-lived individuals. Eur J Hum Genet (2010) 0.77
Tau pathology generated by overexpression of tau. Am J Pathol (1999) 0.77
A 16-amino acid peptide from human alpha2-macroglobulin binds transforming growth factor-beta and platelet-derived growth factor-BB. Protein Sci (2000) 0.76
Alzheimer's Disease. Curr Treat Options Neurol (2000) 0.76
Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients. J Neurol (2013) 0.76
No convincing association between genetic markers and respiratory symptoms: results of a GWA study. Respir Res (2017) 0.75
The genetics of Alzheimer's disease. The number of genetic risk factors associated with this disorder is increasing steadily. BMJ (1998) 0.75
Anti-Ebola MAb 17A3 reacts with bovine and human alpha-2-macroglobulin proteins. J Virol Methods (2010) 0.75
Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. Neurobiol Aging (2013) 0.75
Random-effects models for longitudinal data. Biometrics (1982) 54.17
Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med (1991) 38.78
A polymorphic DNA marker genetically linked to Huntington's disease. Nature (1984) 16.71
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80
Plasmid required for virulence of Agrobacterium tumefaciens. J Bacteriol (1975) 12.83
Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA (1993) 12.83
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30
The family based association test method: strategies for studying general genotype--phenotype associations. Eur J Hum Genet (2001) 9.09
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA (1989) 8.36
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science (1987) 8.29
Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med (1997) 7.22
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci (1996) 7.19
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science (1984) 6.86
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol (2000) 6.40
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III. N Engl J Med (1991) 6.13
Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol (1997) 6.12
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 6.02
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex (1992) 5.57
Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (1994) 5.34
Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered (2003) 5.06
Hospital characteristics associated with adverse events and substandard care. JAMA (1991) 4.77
One or more bound planets per Milky Way star from microlensing observations. Nature (2012) 4.68
MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology (2002) 4.67
Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology (1992) 4.52
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron (2001) 4.42
A discordant-sibship test for disequilibrium and linkage: no need for parental data. Am J Hum Genet (1998) 4.32
APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol (1997) 4.29
STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY. J Exp Med (1946) 4.20
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology (2004) 4.00
Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron (1993) 3.92
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology (2005) 3.90
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci (1999) 3.85
Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry (2002) 3.78
Family-based tests of association in the presence of linkage. Am J Hum Genet (2000) 3.74
Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry (2009) 3.64
Preclinical prediction of Alzheimer's disease using SPECT. Neurology (1998) 3.60
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol (1995) 3.60
The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science (1987) 3.59
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med (1998) 3.23
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science (2000) 3.16
Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci (1999) 3.16
Localization of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere. Cell (1987) 3.11
Age-specific incidence of Alzheimer's disease in a community population. JAMA (1995) 3.09
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med (1996) 3.05
ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology (1997) 3.04
DNA markers for nervous system diseases. Science (1984) 3.02
Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci (1997) 2.91
A study of medical injury and medical malpractice. N Engl J Med (1989) 2.90
Isolation of polymorphic DNA fragments from human chromosome 4. Nucleic Acids Res (1987) 2.83
Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem (1998) 2.78
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol (2000) 2.78
Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med (2001) 2.75
Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. 1991. Qual Saf Health Care (2004) 2.66
Mixture models for the joint distribution of repeated measures and event times. Stat Med (1997) 2.63
Efficiency and robustness of pedigree segregation analysis. Am J Hum Genet (1978) 2.60
Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am J Hum Genet (2000) 2.59
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry (1999) 2.58
Genetics of aging. Science (1997) 2.57
A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics (2001) 2.55
BNaC1 and BNaC2 constitute a new family of human neuronal sodium channels related to degenerins and epithelial sodium channels. Proc Natl Acad Sci U S A (1997) 2.53
Tutorial in Biostatistics: Evaluating the impact of 'critical periods' in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol (2001) 2.53
Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry (2008) 2.50
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 2.49
Identification of adverse events occurring during hospitalization. A cross-sectional study of litigation, quality assurance, and medical records at two teaching hospitals. Ann Intern Med (1990) 2.48
Short term routine antibiotic prophylaxis in surgery. Br J Surg (1974) 2.43
Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med (1996) 2.43
Homozygotes for Huntington's disease. Nature (1987) 2.40
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell (1995) 2.37
Model-based approaches to analysing incomplete longitudinal and failure time data. Stat Med (1997) 2.37
Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 2.36
Head injury and the risk of AD in the MIRAGE study. Neurology (2000) 2.34
Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34
Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol (1986) 2.33
Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem (1999) 2.30
Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet (1993) 2.29
The joining of V and J gene segments creates antibody diversity. Nature (1980) 2.28
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci (1993) 2.27
Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26
Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res (1990) 2.26
Contemporary gastroenteritis of infancy: clinical features and prehospital management. Br Med J (Clin Res Ed) (1984) 2.25
Do general practitioners' attitudes towards depression predict their clinical behaviour? Psychol Med (2000) 2.25
Presenilin-mediated modulation of capacitative calcium entry. Neuron (2000) 2.25
Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. Neuroimage (2007) 2.23
Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med (1981) 2.21